Skip to main content
Erschienen in: Pediatric Radiology 6/2017

19.01.2017 | Pictorial Essay

Muscle MRI in pediatrics: clinical, pathological and genetic correlation

verfasst von: Claudia P. Cejas, Maria M. Serra, David F. Gonzalez Galvez, Eliana A. Cavassa, Ana L. Taratuto, Gabriel A. Vazquez, Mario E. L. Massaro, Angeles V. Schteinschneider

Erschienen in: Pediatric Radiology | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Pediatric myopathies comprise a very heterogeneous group of disorders that may develop at different ages and affect different muscle groups. Its diagnosis is sometimes difficult and must be confirmed by muscle biopsy and/or genetic analysis. In recent years, muscle involvement patterns observed on MRI have become a valuable tool, aiding clinical diagnosis and enriching pathological and genetic assessments. We selected eight myopathy cases from our institutional database in which the pattern of muscle involvement observed on MRI was almost pathognomonic and could therefore contribute to establishing diagnosis. Muscle biopsy, genetic diagnosis or both confirmed all cases.
Literatur
1.
Zurück zum Zitat Straub V, Carlier PG, Mercuri E (2012) TREAT-NMD workshop: pattern recognition in genetic muscle diseases using muscle MRI. Neuromuscul Disord 22 Suppl 2:S42–S53CrossRefPubMed Straub V, Carlier PG, Mercuri E (2012) TREAT-NMD workshop: pattern recognition in genetic muscle diseases using muscle MRI. Neuromuscul Disord 22 Suppl 2:S42–S53CrossRefPubMed
2.
Zurück zum Zitat Mercuri E, Muntoni F (2012) The ever-expanding spectrum of congenital muscular dystrophies. Ann Neurol 72:9–17CrossRefPubMed Mercuri E, Muntoni F (2012) The ever-expanding spectrum of congenital muscular dystrophies. Ann Neurol 72:9–17CrossRefPubMed
3.
Zurück zum Zitat North KN, Wang CH, Clarke N et al (2014) Approach to the diagnosis of congenital myopathies. Neuromuscul Disord 24:97–116CrossRefPubMed North KN, Wang CH, Clarke N et al (2014) Approach to the diagnosis of congenital myopathies. Neuromuscul Disord 24:97–116CrossRefPubMed
4.
5.
Zurück zum Zitat Compeyrot-Lacassagne S, Feldman BM (2007) Inflammatory myopathies in Children. Rheum Dis Clin North Am 33:525–553CrossRefPubMed Compeyrot-Lacassagne S, Feldman BM (2007) Inflammatory myopathies in Children. Rheum Dis Clin North Am 33:525–553CrossRefPubMed
6.
Zurück zum Zitat Pichiecchio A, Tavazzi E (2013) Metabolic myopathies. In: Wattjes MP, Fischer D (eds) Neuromuscular imaging. Springer, New York, pp 127–146CrossRef Pichiecchio A, Tavazzi E (2013) Metabolic myopathies. In: Wattjes MP, Fischer D (eds) Neuromuscular imaging. Springer, New York, pp 127–146CrossRef
7.
8.
Zurück zum Zitat Mercuri E, Jungbluth H, Muntoni F (2005) Muscle imaging in clinical practice: diagnostic value of muscle magnetic resonance imaging in inherited neuromuscular disorders. Curr Opin Neurol 18:526–537CrossRefPubMed Mercuri E, Jungbluth H, Muntoni F (2005) Muscle imaging in clinical practice: diagnostic value of muscle magnetic resonance imaging in inherited neuromuscular disorders. Curr Opin Neurol 18:526–537CrossRefPubMed
9.
Zurück zum Zitat Mercuri E, Pichiecchio A, Allsop J et al (2007) Muscle MRI in inherited neuromuscular disorders: past, present, and future. J Magn Reson Imaging 25:433–440CrossRefPubMed Mercuri E, Pichiecchio A, Allsop J et al (2007) Muscle MRI in inherited neuromuscular disorders: past, present, and future. J Magn Reson Imaging 25:433–440CrossRefPubMed
11.
Zurück zum Zitat Hollingsworth KG, de Sousa PL, Straub V et al (2012) Towards harmonization of protocols for MRI outcome measures in skeletal muscle studies: consensus recommendations from two TREAT-NMD NMR workshops. Neuromuscul Disord 22 Suppl 2:S54–S67CrossRefPubMed Hollingsworth KG, de Sousa PL, Straub V et al (2012) Towards harmonization of protocols for MRI outcome measures in skeletal muscle studies: consensus recommendations from two TREAT-NMD NMR workshops. Neuromuscul Disord 22 Suppl 2:S54–S67CrossRefPubMed
12.
Zurück zum Zitat Schmidt GP, Reiser MF, Baur-Melnyk A (2007) Whole-body MRI of the musculoskeletal system: the value of MR imaging. Skeletal Radiol 36:1109–1119CrossRefPubMedPubMedCentral Schmidt GP, Reiser MF, Baur-Melnyk A (2007) Whole-body MRI of the musculoskeletal system: the value of MR imaging. Skeletal Radiol 36:1109–1119CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Peters SA, Köhler C, Schara U et al (2008) Muscular magnetic resonance imaging for evaluation of myopathies in children. Klin Padiatr 220:37–46CrossRefPubMed Peters SA, Köhler C, Schara U et al (2008) Muscular magnetic resonance imaging for evaluation of myopathies in children. Klin Padiatr 220:37–46CrossRefPubMed
15.
Zurück zum Zitat Kraeva N, Zvaritch E, Rossi AE et al (2013) Novel excitation-contraction uncoupled RYR1 mutations in patients with central core disease. Neuromuscul Disord 23:120–132CrossRefPubMed Kraeva N, Zvaritch E, Rossi AE et al (2013) Novel excitation-contraction uncoupled RYR1 mutations in patients with central core disease. Neuromuscul Disord 23:120–132CrossRefPubMed
16.
Zurück zum Zitat Klein A, Jungbluth H, Clement E et al (2011) Muscle magnetic resonance imaging in congenital myopathies due to ryanodine receptor type I gene mutations. Arch Neurol 68:1171–1179CrossRefPubMed Klein A, Jungbluth H, Clement E et al (2011) Muscle magnetic resonance imaging in congenital myopathies due to ryanodine receptor type I gene mutations. Arch Neurol 68:1171–1179CrossRefPubMed
17.
Zurück zum Zitat Jungbluth H, Davis MR, Müller C et al (2004) Magnetic resonance imaging of muscle in congenital myopathies associated with RYR-1 mutations. Neuromuscul Disord 14:785–790CrossRefPubMed Jungbluth H, Davis MR, Müller C et al (2004) Magnetic resonance imaging of muscle in congenital myopathies associated with RYR-1 mutations. Neuromuscul Disord 14:785–790CrossRefPubMed
19.
20.
Zurück zum Zitat Catteruccia M, Fattori F, Codemo V et al (2013) Centronuclear myopathy related to dynamin 2 mutations: Clinical, morphological, muscle imaging and genetic features of an Italian cohort. Neuromuscul Disord 23:229–238CrossRefPubMedPubMedCentral Catteruccia M, Fattori F, Codemo V et al (2013) Centronuclear myopathy related to dynamin 2 mutations: Clinical, morphological, muscle imaging and genetic features of an Italian cohort. Neuromuscul Disord 23:229–238CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Schessl J, Medne L, Hu Y et al (2007) MRI in DNM2-related centronuclear myopathy: evidence for highly selective muscle involvement. Neuromuscul Disord 17:28–32CrossRefPubMed Schessl J, Medne L, Hu Y et al (2007) MRI in DNM2-related centronuclear myopathy: evidence for highly selective muscle involvement. Neuromuscul Disord 17:28–32CrossRefPubMed
22.
Zurück zum Zitat Belinda S, Cowling BS, Cottle DL et al (2011) Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features. Neuromuscul Disord 21:237–251CrossRef Belinda S, Cowling BS, Cottle DL et al (2011) Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features. Neuromuscul Disord 21:237–251CrossRef
23.
Zurück zum Zitat Cowling BS, McGrath MJ, Nguyen MA et al (2008) Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy. J Cell Biol 183:1033–1048CrossRefPubMedPubMedCentral Cowling BS, McGrath MJ, Nguyen MA et al (2008) Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy. J Cell Biol 183:1033–1048CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Selcen D, Bromberg MB, Chin SS et al (2011) Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy. Neurology 77:1951–1959CrossRefPubMedPubMedCentral Selcen D, Bromberg MB, Chin SS et al (2011) Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy. Neurology 77:1951–1959CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Astrea G, Schessl J, Clement E et al (2009) Muscle MRI in FHL1-linked reducing body myopathy. Neuromuscul Disord 19:689–691CrossRefPubMed Astrea G, Schessl J, Clement E et al (2009) Muscle MRI in FHL1-linked reducing body myopathy. Neuromuscul Disord 19:689–691CrossRefPubMed
26.
Zurück zum Zitat Wewer UM, Engvall E (1996) Merosin/laminin-2 and muscular dystrophy. Neuromuscul Disord 6:409–418CrossRefPubMed Wewer UM, Engvall E (1996) Merosin/laminin-2 and muscular dystrophy. Neuromuscul Disord 6:409–418CrossRefPubMed
28.
Zurück zum Zitat Quijano-Roy S, Avila-Smirnow, Carlier R (2011) Merosin deficient in congenital muscular dystrophy. In: Wattjes M, Fischer D (eds) Neuromuscular imaging. Springer, New York, pp 177–187 Quijano-Roy S, Avila-Smirnow, Carlier R (2011) Merosin deficient in congenital muscular dystrophy. In: Wattjes M, Fischer D (eds) Neuromuscular imaging. Springer, New York, pp 177–187
29.
Zurück zum Zitat Oto A, Aydingöz U, Başgün N et al (2001) MR imaging of pelvic and thigh muscles in congenital muscular dystrophy. Turk J Pediatr 43:44–51PubMed Oto A, Aydingöz U, Başgün N et al (2001) MR imaging of pelvic and thigh muscles in congenital muscular dystrophy. Turk J Pediatr 43:44–51PubMed
30.
Zurück zum Zitat Yonekawa T, Nishino I (2015) Ullrich congenital muscular dystrophy: clinicopathological features, natural history and pathomechanism(s). J Neurol Neurosurg Psychiatry 86:280–287CrossRefPubMed Yonekawa T, Nishino I (2015) Ullrich congenital muscular dystrophy: clinicopathological features, natural history and pathomechanism(s). J Neurol Neurosurg Psychiatry 86:280–287CrossRefPubMed
31.
Zurück zum Zitat Ishikawa H, Sugie K, Murayama K et al (2004) Ullrich disease due to deficiency of collagen VI in the sarcolemma. Neurology 62:620–623CrossRefPubMed Ishikawa H, Sugie K, Murayama K et al (2004) Ullrich disease due to deficiency of collagen VI in the sarcolemma. Neurology 62:620–623CrossRefPubMed
32.
Zurück zum Zitat Carlier RY, Mompoint D, Avila-Smirnow D et al (2010) Whole-body muscle magnetic resonance imaging in collagen type VI -related myopathies (Ullrich congenital muscular dystrophy and Bethlem myopathy). Scientific Exhibit presented at the European Congress of Radiology, Vienna Carlier RY, Mompoint D, Avila-Smirnow D et al (2010) Whole-body muscle magnetic resonance imaging in collagen type VI -related myopathies (Ullrich congenital muscular dystrophy and Bethlem myopathy). Scientific Exhibit presented at the European Congress of Radiology, Vienna
33.
Zurück zum Zitat Mercuri E, Cini C, Pichiecchio A et al (2003) Muscle magnetic resonance imaging in patients with congenital muscular dystrophy and Ullrich phenotype. Neuromuscul Disord 13:554–558CrossRefPubMed Mercuri E, Cini C, Pichiecchio A et al (2003) Muscle magnetic resonance imaging in patients with congenital muscular dystrophy and Ullrich phenotype. Neuromuscul Disord 13:554–558CrossRefPubMed
34.
Zurück zum Zitat Mercuri E, Lampe A, Allsop J et al (2005) Muscle MRI in Ullrich congenital muscular dystrophy and Bethlem myopathy. Neuromuscul Disord 15:303–310CrossRefPubMed Mercuri E, Lampe A, Allsop J et al (2005) Muscle MRI in Ullrich congenital muscular dystrophy and Bethlem myopathy. Neuromuscul Disord 15:303–310CrossRefPubMed
35.
Zurück zum Zitat Gowers WR (1879) Pseudo-hypertrophic muscular Paralysis-A clinical lecture. J & A Churchill, London Gowers WR (1879) Pseudo-hypertrophic muscular Paralysis-A clinical lecture. J & A Churchill, London
36.
37.
39.
Zurück zum Zitat Finanger EL, Russman B, Forbes SC et al (2012) Use of skeletal muscle MRI in diagnosis and monitoring disease progression in Duchenne muscular dystrophy. Phys Med Rehabil Clin N Am 23:1–10CrossRefPubMed Finanger EL, Russman B, Forbes SC et al (2012) Use of skeletal muscle MRI in diagnosis and monitoring disease progression in Duchenne muscular dystrophy. Phys Med Rehabil Clin N Am 23:1–10CrossRefPubMed
40.
Zurück zum Zitat Iaccarino L, Ghirardello A, Bettio S et al (2014) The clinical features, diagnosis and classification of dermatomyositis. J Autoimmun 48–49:122–127CrossRefPubMed Iaccarino L, Ghirardello A, Bettio S et al (2014) The clinical features, diagnosis and classification of dermatomyositis. J Autoimmun 48–49:122–127CrossRefPubMed
41.
Zurück zum Zitat Malattia C, Damasio MB, Madeo A et al (2014) Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis. Ann Rheum Dis 73:1083–1090CrossRefPubMed Malattia C, Damasio MB, Madeo A et al (2014) Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis. Ann Rheum Dis 73:1083–1090CrossRefPubMed
42.
Zurück zum Zitat Castro TC, Lederman H, Terreri MT et al (2014) Whole-body magnetic resonance imaging in the assessment of muscular involvement in juvenile dermatomyositis/polymyositis patients. Scand J Rheumatol 43:329–333CrossRefPubMed Castro TC, Lederman H, Terreri MT et al (2014) Whole-body magnetic resonance imaging in the assessment of muscular involvement in juvenile dermatomyositis/polymyositis patients. Scand J Rheumatol 43:329–333CrossRefPubMed
Metadaten
Titel
Muscle MRI in pediatrics: clinical, pathological and genetic correlation
verfasst von
Claudia P. Cejas
Maria M. Serra
David F. Gonzalez Galvez
Eliana A. Cavassa
Ana L. Taratuto
Gabriel A. Vazquez
Mario E. L. Massaro
Angeles V. Schteinschneider
Publikationsdatum
19.01.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Radiology / Ausgabe 6/2017
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-016-3777-6

Weitere Artikel der Ausgabe 6/2017

Pediatric Radiology 6/2017 Zur Ausgabe

Hermes

Hermes

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.